Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
FDA/EMA/Drug Designation
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
FDA/EMA/Drug Designation
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
FDA/EMA/Drug Designation
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
FDA/EMA/Drug Designation
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
FDA/EMA/Drug Designation
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
FDA/EMA/Drug Designation
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
FDA/EMA/Drug Designation
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Clinical
FDA/EMA/Drug Designation
FDA/EMA/Drug Designation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA/EMA/Drug Designation
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany Swiss Stock Exchange:RO
Globenewswire News
-
February 26, 2021
FDA/EMA/Drug Designation
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
FDA/EMA/Drug Designation
Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell...
FDA/EMA/Drug Designation
EMA issues advice on casirivimab and imdevimab antibody cocktail for the treatment of mild-to-moderate COVID-19 Swiss Stock Exchange:RO
FDA/EMA/Drug Designation
4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ
FDA/EMA/Drug Designation
Roche receives positive CHMP opinion for Evrysdi, the first and only...
Globenewswire News
-
February 26, 2021
0
FDA/EMA/Drug Designation
Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare...
Globenewswire News
-
February 26, 2021
0
FDA/EMA/Drug Designation
GC Pharma Submits Biologics License Application to US FDA for Immune...
Biospace News
-
February 26, 2021
0
FDA/EMA/Drug Designation
Assembly Biosciences Updates Pipeline Strategy, Focusing on Finite and Curative Therapies...
Firstwordpharma News
-
February 26, 2021
0
FDA/EMA/Drug Designation
Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare...
Biospace News
-
February 26, 2021
0
1
2
3
...
139
Page 1 of 139
- Advertisement -
MOST POPULAR
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast)...
October 28, 2019
Calithera Biosciences Initiates Phase 1 Trial of Arginase Inhibitor CB-280 for...
February 21, 2019
Glenmark to spin off its innovation business into a new company...
February 14, 2019
Study sheds light on damage linked to ageing
February 14, 2019
Load more
HOT NEWS
Commercial
Biden, Harris Unveil Prescription Drug Pricing Plans
Acquisitions
Novartis announces NEJM publication of three pivotal trials showing durable and...
Commercial
Exclusive: Fusion Secures $105 Million, Will Double Headcount
Acquisitions
Merck to Acquire Immune Design
